The Northern General Hospital is a large teaching hospital and Major Trauma Centre in Sheffield, England. Its departments include Accident and Emergency for adults, with children being treated at the Sheffield Children's Hospital on Western Bank.

There are 1,100 beds in Northern General Hospital.

During the past decade, Northern General Hospital conducted 36 clinical trials. In the 10-year time frame, 36 clinical trials started and 14 clinical trials were completed, i.e. on average, 38.9% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 8 clinical trials were completed. i.e. 72.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Northern General Hospital" #1 sponsor was "Sheffield Teaching Hospitals NHS Foundation Trust" with 6 trials, followed by "Boston Scientific Corporation" with 5 trials sponsored, "University College, London" with 4 trials sponsored, "University of Edinburgh" with 3 trials sponsored and "Boehringer Ingelheim" with 3 trials sponsored. Other sponsors include 44 different institutions and companies that sponsored additional 49 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Northern General Hospital" #1 collaborator was "National Institute for Health Research, United Kingdom" with 3 trials as a collaborator, "British Heart Foundation" with 2 trials as a collaborator, "Guy's and St Thomas' NHS Foundation Trust" with 2 trials as a collaborator, "London School of Hygiene and Tropical Medicine" with 2 trials as a collaborator and "NHS Lothian" with 2 trials as a collaborator. Other collaborators include 83 different institutions and companies that were collaborators in the rest 92 trials.

According to Clinical.Site data, the most researched conditions in "Northern General Hospital" are "Heart Failure" (4 trials), "Idiopathic Pulmonary Fibrosis" (4 trials), "Acute Coronary Syndrome" (3 trials), "Coronary Artery Disease" (3 trials) and "Asthma" (2 trials). Many other conditions were trialed in "Northern General Hospital" in a lesser frequency.

Most popular intervention types in "Northern General Hospital" are "Drug" (28 trials), "Device" (20 trials), "Procedure" (8 trials), "Biological" (6 trials) and "Other" (6 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (10 trials), "Aspirin" (2 trials), "Control" (2 trials), "Percutaneous Coronary Intervention" (2 trials) and "Pirfenidone" (2 trials). Other intervention names were less common.

The vast majority of trials in "Northern General Hospital" are 69 trials for "All" genders.

Currently, there are NaN active trials in "Northern General Hospital". undefined are not yet recruiting, 4 are recruiting, 10 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 40 completed trials in Northern General Hospital, undefined suspended trials, and 8 terminated clinical trials to date.

Out of the total trials that were conducted in Northern General Hospital, 2 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 25 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 21 trials that are defined as “Not Applicable".